HSA
REGN icon

Hussman Strategic Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Hussman Strategic Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,100
Closed -$1.33M – 278
2025
Q1 		$1.33M Hold
2,100
– – 0.32% 121
2024
Q4 		$1.5M Buy
+2,100
New +$1.76M 0.44% 94
2024
Q2 		– Sell
-2,100
Closed -$2.02M – 245
2024
Q1 		$2.02M Sell
2,100
-2,100
-50% -$2M 0.47% 85
2023
Q4 		$3.69M Hold
4,200
– – 0.84% 25
2023
Q3 		$3.46M Sell
4,200
-3,600
-46% -$2.83M 0.66% 34
2023
Q2 		$5.6M Hold
7,800
– – 1.03% 8
2023
Q1 		$6.41M Hold
7,800
– – 1.01% 5
2022
Q4 		$5.63M Sell
7,800
-1,500
-16% -$1.11M 0.92% 11
2022
Q3 		$6.41M Sell
9,300
-1,050
-10% -$661K 1.11% 6
2022
Q2 		$6.12M Buy
10,350
+4,110
+66% +$2.67M 1.05% 10
2022
Q1 		$4.36M Buy
6,240
+1,040
+20% +$658K 0.85% 13
2021
Q4 		$3.28M Buy
+5,200
New +$3.2M 0.72% 22
2020
Q3 		– Sell
-4,100
Closed -$2.56M – 300
2020
Q2 		$2.56M Hold
4,100
– – 0.65% 39
2020
Q1 		$2M Buy
4,100
+1,600
+64% +$660K 0.54% 56
2019
Q4 		$939K Sell
2,500
-2,500
-50% -$841K 0.3% 125
2019
Q3 		$1.39M Hold
5,000
– – 0.39% 96
2019
Q2 		$1.56M Sell
5,000
-2,500
-33% -$832K 0.44% 94
2019
Q1 		$3.08M Buy
+7,500
New +$3.09M 0.75% 36

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hussman Strategic Advisors's REGN Position: Q2 2025 in Review

Hussman Strategic Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 2,100 shares — an estimated $1.33M sold.

Hussman Strategic Advisors first reported a position in REGN in Q1 2019 and held it in 18 quarters. The position peaked at $6.41M in Q1 2023. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Hussman Strategic Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 2,100 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $1.33M.
  • Hussman Strategic Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2019 and held it in 18 quarters.
  • Hussman Strategic Advisors's Regeneron Pharmaceuticals position peaked at $6.41M in Q1 2023.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Hussman Strategic Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.